Breast cancer statistics, 2015: Convergence of incidence rates between black and white women

In this article, the American Cancer Society provides an overview of female breast cancer statistics in the United States, including data on incidence, mortality, survival, and screening. Approximately 231,840 new cases of invasive breast cancer and 40,290 breast cancer deaths are expected to occur among US women in 2015. Breast cancer incidence rates increased among non‐Hispanic black (black) and Asian/Pacific Islander women and were stable among non‐Hispanic white (white), Hispanic, and American Indian/Alaska Native women from 2008 to 2012. Although white women have historically had higher incidence rates than black women, in 2012, the rates converged. Notably, during 2008 through 2012, incidence rates were significantly higher in black women compared with white women in 7 states, primarily located in the South. From 1989 to 2012, breast cancer death rates decreased by 36%, which translates to 249,000 breast cancer deaths averted in the United States over this period. This decrease in death rates was evident in all racial/ethnic groups except American Indians/Alaska Natives. However, the mortality disparity between black and white women nationwide has continued to widen; and, by 2012, death rates were 42% higher in black women than in white women. During 2003 through 2012, breast cancer death rates declined for white women in all 50 states; but, for black women, declines occurred in 27 of 30 states that had sufficient data to analyze trends. In 3 states (Mississippi, Oklahoma, and Wisconsin), breast cancer death rates in black women were stable during 2003 through 2012. Widening racial disparities in breast cancer mortality are likely to continue, at least in the short term, in view of the increasing trends in breast cancer incidence rates in black women. CA Cancer J Clin 2016;31–42. © 2015 American Cancer Society.

[1]  D. Parkin Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy? , 2009, European journal of cancer.

[2]  D. Berry,et al.  Effect of screening and adjuvant therapy on mortality from breast cancer. , 2006, The New England journal of medicine.

[3]  Oguzhan Alagoz,et al.  Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality. , 2014, Journal of the National Cancer Institute.

[4]  Y. Liao,et al.  Misclassification of Survey Responses and Black-White Disparity in Mammography Use, Behavioral Risk Factor Surveillance System, 1995-2006 , 2011, Preventing chronic disease.

[5]  C. Perou,et al.  Epidemiology of basal-like breast cancer , 2008, Breast Cancer Research and Treatment.

[6]  P. Remington,et al.  Socioeconomic Status and Survival after an invasive Breast Cancer Diagnosis , 2010, Cancer Epidemiology, Biomarkers and Prevention.

[7]  J. Lortet-Tieulent,et al.  Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. , 2015, JAMA.

[8]  M. Dieci,et al.  Rare breast cancer subtypes: histological, molecular, and clinical peculiarities. , 2014, The oncologist.

[9]  Zhao Chen,et al.  Ethnicity and breast cancer: factors influencing differences in incidence and outcome. , 2005, Journal of the National Cancer Institute.

[10]  K. Altundag,et al.  Reproductive and hormonal risk factors for postmenopausal luminal, HER‐2‐overexpressing, and triple‐negative breast cancer , 2009, Cancer.

[11]  K. Dookeran,et al.  Racial and Ethnic Differences in Breast Cancer Survival: How Much Is Explained by Screening, Tumor Severity, Biology, Treatment, Comorbidities, and Demographics? , 2008 .

[12]  J. Heck,et al.  Delays in breast cancer diagnosis and treatment by racial/ethnic group. , 2006, Archives of internal medicine.

[13]  Amy Y. Chen,et al.  Insurance status and stage of cancer at diagnosis among women with breast cancer , 2007, Cancer.

[14]  Rebecca Smith-Bindman,et al.  Racial and ethnic differences in breast cancer survival , 2008, Cancer.

[15]  Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors , 2013, Breast Cancer Research.

[16]  S. Gomez,et al.  Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[17]  A. Jemal,et al.  Prevalence of Major Risk Factors and Use of Screening Tests for Cancer in the United States , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[18]  K. Lunetta,et al.  Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium. , 2014, Journal of the National Cancer Institute.

[19]  Plasma carotenoids and breast cancer risk in the Cancer Prevention Study II Nutrition Cohort , 2015, Cancer Causes & Control.

[20]  Eric J Feuer,et al.  The decrease in breast-cancer incidence in 2003 in the United States. , 2007, The New England journal of medicine.

[21]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[22]  C. Parise,et al.  Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000–2010 , 2013, BMC Cancer.

[23]  Victoria L. Cafourek,et al.  Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. , 2011, Journal of the National Cancer Institute.

[24]  A. Gompel Breast cancer incidence rates in US women are no longer declining. , 2011, Climacteric : the journal of the International Menopause Society.

[25]  C. Perou,et al.  How many etiological subtypes of breast cancer: two, three, four, or more? , 2014, Journal of the National Cancer Institute.

[26]  G. Colditz,et al.  Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer , 2011, Breast Cancer Research and Treatment.

[27]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[28]  J. Lynch,et al.  Trends in Area-Socioeconomic and Race-Ethnic Disparities in Breast Cancer Incidence, Stage at Diagnosis, Screening, Mortality, and Survival among Women Ages 50 Years and Over (1987-2005) , 2009, Cancer Epidemiology Biomarkers & Prevention.

[29]  W. Thompson,et al.  Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger , 2011, Breast Cancer Research and Treatment.

[30]  Richard J. K. Taylor,et al.  The impact of changes in hormone therapy on breast cancer incidence in the US population , 2009, Cancer Causes & Control.

[31]  A. Jemal,et al.  Breast cancer statistics, 2013 , 2014, CA: a cancer journal for clinicians.

[32]  Charles M Perou,et al.  Systems biology and genomics of breast cancer. , 2011, Cold Spring Harbor perspectives in biology.

[33]  H. Morrison,et al.  Breast cancer incidence and hormone replacement therapy in Canada. , 2010, Journal of the National Cancer Institute.

[34]  P. Porter,et al.  Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20–44 years of age , 2012, Breast Cancer Research and Treatment.

[35]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[36]  R. Shi,et al.  Effects of payer status on breast cancer survival: a retrospective study , 2015, BMC Cancer.

[37]  D. Silverman,et al.  Cancer incidence and mortality trends among whites in the United States, 1947-84. , 1987, Journal of the National Cancer Institute.

[38]  Graham A. Colditz,et al.  Trends in breast cancer incidence and mortality in the United States: implications for prevention , 2013, Breast Cancer Research and Treatment.

[39]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[40]  J. Ranstam,et al.  Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease , 2002, The Lancet.

[41]  S. Curtin,et al.  Births: final data for 2013. , 2015, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[42]  M. Yaffe,et al.  American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007, CA: a cancer journal for clinicians.

[43]  L. Goldman,et al.  Accuracy of Diagnostic Mammography at Facilities Serving Vulnerable Women , 2011, Medical care.

[44]  J. Palmer,et al.  Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop. , 2013, Journal of the National Cancer Institute.

[45]  Päivi Heikkilä,et al.  Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies , 2010, PLoS medicine.

[46]  Ping Sun,et al.  Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. , 2015, JAMA.

[47]  P. Kyyrönen,et al.  Postmenopausal hormone drugs and breast and colon cancer: Nordic countries 1995-2005. , 2008, Maturitas.

[48]  Helen Farrugia,et al.  Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia , 2009, The Medical journal of Australia.

[49]  P. Rosenberg,et al.  Tracking and evaluating molecular tumor markers with cancer registry data: HER2 and breast cancer. , 2014, Journal of the National Cancer Institute.

[50]  A. Jemal,et al.  Breast Cancer Statistics , 2013 .

[51]  M. Paesmans,et al.  Update of the evolution of breast cancer incidence in relation to hormone replacement therapy use in Belgium. , 2012, Maturitas.

[52]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[53]  O. Olopade,et al.  A perfect storm: How tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change , 2015, CA: a cancer journal for clinicians.

[54]  R. Connelly,et al.  Analysis of trends in age-adjusted incidence rates for 10 major sites of cancer. , 1972, American journal of public health.

[55]  G. Rauscher,et al.  Validating Self-Reported Mammography Use in Vulnerable Communities: Findings and Recommendations , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[56]  S. Ooi,et al.  Disparities in breast cancer characteristics and outcomes by race/ethnicity , 2011, Breast Cancer Research and Treatment.

[57]  S. Anand,et al.  Declining incidence of breast cancer after decreased use of hormone-replacement therapy: magnitude and time lags in different countries , 2011, Journal of Epidemiology & Community Health.

[58]  S. Yao,et al.  Parity and breastfeeding among African-American women: differential effects on breast cancer risk by estrogen receptor status in the Women’s Circle of Health Study , 2013, Cancer Causes & Control.

[59]  W. Willett,et al.  Fruit and vegetable intake and risk of breast cancer by hormone receptor status. , 2013, Journal of the National Cancer Institute.

[60]  Jeffrey H Silber,et al.  Characteristics associated with differences in survival among black and white women with breast cancer. , 2013, JAMA.

[61]  A. Jemal,et al.  Breast Cancer Incidence Rates in U.S. Women Are No Longer Declining , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[62]  B. Rosner,et al.  Plasma carotenoids and risk of breast cancer over 20 y of follow-up. , 2015, The American journal of clinical nutrition.

[63]  R. Tamimi,et al.  Established breast cancer risk factors and risk of intrinsic tumor subtypes. , 2015, Biochimica et biophysica acta.

[64]  A. Olshan,et al.  Obesity, body fat distribution, and risk of breast cancer subtypes in African American women participating in the AMBER Consortium , 2015, Breast Cancer Research and Treatment.

[65]  E. Feuer,et al.  Bias Associated With Self-Report of Prior Screening Mammography , 2009, Cancer Epidemiology Biomarkers & Prevention.

[66]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[67]  C. Perou,et al.  Defining breast cancer intrinsic subtypes by quantitative receptor expression. , 2015, The oncologist.